On THIS message board, nobody is even PRETENDING that RXPC "certs" are worth anything or ever WILL be worth anything. The Reverse Backdoor Creative Creeping Triangular merger rumor ran out of gas. MacLellan is distancing himself from Radient Pharmaceuticals and so are the Aussies, while Gartner is supposedly merging his company with another zombie biotech in Oregon. Provista gave up on Radient and DR-70 years ago as proven by their White Papers and Journal Publications.
All we are doing here is reminiscing about Radient and waiting for something to happen with CSTAMDL (the Hong Kong company that took all Radient's assets) or GCDx (the company that is trying to sell DR-70 off patent here in the USA). QuantRx Biomedical, the company with which GCDx is supposedly merging, will probably file a 10K in March that perhaps will explain where the $50,000 went -- although I think we all know where that $50k went.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.